Evercore ISI Group Reiterates Outperform Rating on West Pharmaceutical Services, Inc. (WST)

Market Context

West Pharmaceutical Services, Inc. operates in the Healthcare sector. The stock currently trades at $331.25 with a market capitalization of $19.6B. The stock has gained 25.6% over the past 52 weeks.

Analyst coverage from Evercore ISI Group provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for West Pharmaceutical Services, Inc..

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for West Pharmaceutical Services, Inc.

Among the 10 most recent ratings: 6 Buy, 4 Hold, 0 Sell.

Date	Firm	Rating	Price Target
Jul 27, 2026	Evercore ISI Group	Outperform	N/A
Jul 13, 2026	BNP Paribas	Outperform	N/A
Jul 09, 2026	Morgan Stanley	Equal-Weight	N/A
Jul 06, 2026	Evercore ISI Group	Outperform	N/A
Jul 02, 2026	Keybanc	Overweight	N/A

Related Tools: Analyst Ratings Dashboard | View WST Stock Page